A detailed history of Vanguard Group Inc transactions in Axogen, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,425,789 shares of AXGN stock, worth $35.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,425,789
Previous 2,411,916 0.58%
Holding current value
$35.3 Million
Previous $17.5 Million 94.76%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$7.52 - $14.69 $104,324 - $203,794
13,873 Added 0.58%
2,425,789 $34 Million
Q2 2024

Aug 13, 2024

BUY
$5.67 - $8.06 $2,908 - $4,134
513 Added 0.02%
2,411,916 $17.5 Million
Q1 2024

May 10, 2024

SELL
$6.63 - $10.69 $358,636 - $578,254
-54,093 Reduced 2.19%
2,411,403 $19.5 Million
Q4 2023

Feb 14, 2024

SELL
$3.61 - $7.76 $47,020 - $101,074
-13,025 Reduced 0.53%
2,465,496 $16.8 Million
Q3 2023

Nov 14, 2023

BUY
$4.68 - $9.26 $264,588 - $523,523
56,536 Added 2.33%
2,478,521 $12.4 Million
Q2 2023

Aug 14, 2023

BUY
$8.5 - $10.38 $572,415 - $699,020
67,343 Added 2.86%
2,421,985 $22.1 Million
Q1 2023

May 15, 2023

BUY
$7.53 - $10.95 $3.02 Million - $4.4 Million
401,473 Added 20.55%
2,354,642 $22.3 Million
Q4 2022

Feb 10, 2023

BUY
$9.44 - $13.09 $444,869 - $616,879
47,126 Added 2.47%
1,953,169 $19.5 Million
Q3 2022

Nov 14, 2022

BUY
$8.14 - $12.25 $128,196 - $192,925
15,749 Added 0.83%
1,906,043 $22.7 Million
Q2 2022

Aug 12, 2022

SELL
$6.99 - $10.0 $228,370 - $326,710
-32,671 Reduced 1.7%
1,890,294 $15.5 Million
Q1 2022

May 13, 2022

BUY
$7.26 - $10.7 $282,907 - $416,957
38,968 Added 2.07%
1,922,965 $15.3 Million
Q4 2021

Feb 14, 2022

BUY
$8.8 - $16.0 $209,369 - $380,672
23,792 Added 1.28%
1,883,997 $17.7 Million
Q3 2021

Nov 12, 2021

BUY
$15.23 - $21.72 $1.17 Million - $1.66 Million
76,573 Added 4.29%
1,860,205 $29.4 Million
Q2 2021

Aug 13, 2021

BUY
$17.8 - $23.5 $31.7 Million - $41.9 Million
1,783,632 New
1,783,632 $38.5 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $616M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.